Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 3 years, the average EPS without NRI Growth Rate was 69.10% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 54.90% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 23.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Clinical Laserthermia Systems AB was 69.10% per year. The lowest was -80.10% per year. And the median was -4.70% per year.
Clinical Laserthermia Systems AB (FRA:LS60) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Clinical Laserthermia Systems AB 3-Year EPS without NRI Growth Rate Related Terms
FRA:LS60 vs ABT, SYK, MDT: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, Clinical Laserthermia Systems AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinical Laserthermia Systems AB 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Clinical Laserthermia Systems AB's 3-Year EPS without NRI Growth Rate falls into.
Clinical Laserthermia Systems AB 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 69.10% mean?
Clinical Laserthermia Systems AB (FRA:LS60) has a 3-Year EPS without NRI Growth Rate of 69.10% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Clinical Laserthermia Systems AB and its competitors. According to the industry distribution chart, Clinical Laserthermia Systems AB ranks #27 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 4.1%.
Is Clinical Laserthermia Systems AB's 3-Year EPS without NRI Growth Rate too high?
Clinical Laserthermia Systems AB's current 3-Year EPS without NRI Growth Rate is 69.10%. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 7.75. Clinical Laserthermia Systems AB's value of 69.10% is 791.6% above this industry median. Based on the distribution chart, Clinical Laserthermia Systems AB ranks #27 out of 662 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's 3-Year EPS without NRI Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Clinical Laserthermia Systems AB ranks #27 out of 662 companies for 3-Year EPS without NRI Growth Rate. This places Clinical Laserthermia Systems AB in the top 4% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 7.75. Clinical Laserthermia Systems AB's value of 69.10% is 791.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 7.75, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clinical Laserthermia Systems AB's current 3-Year EPS without NRI Growth Rate of 69.10% is 791.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Clinical Laserthermia Systems AB and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinical Laserthermia Systems AB's current 3-Year EPS without NRI Growth Rate is 69.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (FRA:LS60) is currently considered Possible Value Trap. The stock's GF Value™ is €0.16, compared to a current price of €0.12 — trading 25% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 69.10% and 791.6% above the Medical Devices & Instruments industry median of 7.75. Clinical Laserthermia Systems AB's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (FRA:LS60), the current 3-Year EPS without NRI Growth Rate is 69.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued.
The current stock price of €0.12 is trading 25% below its estimated GF Value™ of €0.16.
GuruFocus considers Clinical Laserthermia Systems AB to be Possible Value Trap.
Key valuation signals for FRA:LS60:
3-Year EPS without NRI Growth Rate: 69.10%
GF Value™: €0.16 vs. price of €0.12 (25% below fair value)
Industry Position: 791.6% above the Medical Devices & Instruments median (#27 of 662)
No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
41GF Score
Get the complete analysis for FRA:LS60
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LS60 has been successfully added to your 
